LACK OF AN IMPORTANT INFLUENCE OF CYP2D6 OXIDATION STATUS ON THE PHARMACOKINETICS OF MOCLOBEMIDE

被引：0
|
作者：
GUENTERT, TW [1 ]
GRANGE, S [1 ]
BOCK, J [1 ]
WALDBURGER, R [1 ]
BIRNBOECK, H [1 ]
HOFFMANNLAROCHE, F [1 ]
机构：
[1] F HOFFMANN LA ROCHE & CO LTD,CH-4002 BASEL,SWITZERLAND
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 1995年 / 57卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：151 / 151
页数：1
相关论文
共 50 条
  • [41] Influence of CYP2C9 and CYP2D6 polymorphisms on the pharmacokinetics of nateglinide in genotyped healthy volunteers
    Kirchheiner, J
    Meineke, I
    Müller, G
    Bauer, S
    Rohde, W
    Meisel, C
    Roots, I
    Brockmöller, J
    CLINICAL PHARMACOKINETICS, 2004, 43 (04) : 267 - 278
  • [42] Is CYP2D6 phenotype predictable from CYP2D6 genotype?
    Kiss, Adam Ferenc
    Toth, Katalin
    Juhasz, Cintia
    Temesvari, Manna
    Paulik, Jozsef
    Hirka, Gabor
    Monostory, Katalin
    MICROCHEMICAL JOURNAL, 2018, 136 : 209 - 214
  • [43] Influence of CYP2C9 and CYP2D6 Polymorphisms on the Pharmacokinetics of Nateglinide in Genotyped Healthy Volunteers
    Julia Kirchheiner
    Ingolf Meineke
    Göran Müller
    Steffen Bauer
    Wolfgang Rohde
    Christian Meisel
    Ivar Roots
    Jürgen Brockmöller
    Clinical Pharmacokinetics, 2004, 43 : 267 - 278
  • [44] Influence of CYP2D6 and CYP2C19 genetic polymorphism on the pharmacokinetics of tolperisone in healthy volunteers
    Pawlowska, M.
    Bogiel, M.
    Duda, J.
    Sieradzki, E.
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2015, 71 (06) : 699 - 705
  • [45] Influence of CYP2D6 and CYP2C19 genetic polymorphism on the pharmacokinetics of tolperisone in healthy volunteers
    M. Pawlowska
    M. Bogiel
    J. Duda
    E. Sieradzki
    European Journal of Clinical Pharmacology, 2015, 71 : 699 - 705
  • [46] Lack of influence of CYP2D6 genotype on the clearance of (R)-, (S)- and racemic-methadon
    Coller, J. K.
    Joergensen, C.
    Foster, D. J. R.
    James, H.
    Gillis, D.
    Christrup, L.
    Somogyi, A. A.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2007, 45 (07) : 410 - 417
  • [47] Influence of CYP2D6*2 and CYP2D6*4 alleles on phenotype in polymedicated depressed inpatients:: therapeutic consequences?
    Haffen, E
    Vandel, P
    Paintaud, G
    Broly, F
    Vandel, S
    Bonin, B
    Bizouard, P
    Sechter, D
    Bechtel, PR
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2000, 55 (11-12) : 877 - 879
  • [48] Influence of CYP2D6*2 and CYP2D6*4 alleles on phenotype in polymedicated depressed inpatients: therapeutic consequences?
    E. Haffen
    P. Vandel
    G. Paintaud
    F. Broly
    S. Vandel
    B. Bonin
    P. Bizouard
    D. Sechter
    P. R. Bechtel
    European Journal of Clinical Pharmacology, 2000, 55 : 877 - 879
  • [49] Genetic influence of CYP2D6 on pharmacokinetics and acute subjective effects of LSD in a pooled analysis
    Patrick Vizeli
    Isabelle Straumann
    Friederike Holze
    Yasmin Schmid
    Patrick C. Dolder
    Matthias E. Liechti
    Scientific Reports, 11
  • [50] CYP2D6 and CYP3A influence tamoxifen and endoxifen
    Laffman-Johnson, Elise
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2014, 96 (05) : 524 - 525
12345